Scott Gottlieb

Latest articles

16h
FOX 6 Milwaukee
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasrelapse or become resistant to treatments, which may include chemotherapy, stem
FOX 6 Milwaukee / Posted 16 hours ago
relapse or become resistant to treatments, which may include chemotherapy, stem cell transplants, and immunotherapy. Dr. Scott Gottlieb, commissioner of the FDA, noted in a statement announcing the approval Wednesday, how gene therapy has “gone... Read more
113 related articles
18h
KFVS 12 Cape Girardeau
Gene therapy approved for b-cell lymphomaa promising concept to a practical solution to deadly and largely untreatable f
KFVS 12 Cape Girardeau / Posted 18 hours ago
a promising concept to a practical solution to deadly and largely untreatable forms of cancer," said FDA Commissioner Dr. Scott Gottlieb. "We remain committed to supporting the efficient development of safe and effective treatments that leverage... Read more
113 related articles
20h
The Tampa Tribune
Coming soon at two Tampa Bay area hospitals: a cancer treatment that could replace chemoa specific molecule on the T-cell, which tells it to activate a fight when it s
The Tampa Tribune / Posted 20 hours ago
a specific molecule on the T-cell, which tells it to activate a fight when it sees only a cancer cell." FDA Commissioner Scott Gottlieb called it "a new frontier in medical innovation" with "the potential to transform medicine." Locke treated... Read more
113 related articles
22h
Channel NewsAsia
FDA teams with medical companies in Puerto Rico to tackle shortagesisland on Sept. 20, knocking out electricity and causing widespread damage to h
Channel NewsAsia / Posted 22 hours ago
island on Sept. 20, knocking out electricity and causing widespread damage to homes and infrastructure. FDA Commissioner Scott Gottlieb said the agency has been monitoring more than 40 drug products in Puerto Rico, where 10 percent of the drugs... Read more
1d
iafrica.com
2nd gene therapy against cancer approvedmilestone in the development of a whole new scientific paradigm for the treatme
iafrica.com / Posted yesterday
milestone in the development of a whole new scientific paradigm for the treatment of serious diseases," FDA Commissioner Scott Gottlieb said in a statement late Wednesday. "In just several decades, gene therapy has gone from being a promising... Read more
113 related articles
1d
WGEM Quincy
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WGEM Quincy / Posted yesterday
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
1d
WDAM-TV Hattiesburg
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WDAM-TV Hattiesburg / Posted yesterday
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
1d
San Francisco Chronicle
FDA approves second gene-altering treatment for cancerin the development of a whole new scientific paradigm for the treatment of seri
San Francisco Chronicle / Posted yesterday
in the development of a whole new scientific paradigm for the treatment of serious diseases,” the FDA commissioner, Dr. Scott Gottlieb, said in a statement. “In just several decades, gene therapy has gone from being a promising concept to a... Read more
113 related articles
1d
Baltimore Sun
FDA commissioner touts effort to reduce nicotine in cigarettes to Baltimore audiencehas a bold proposal to get people to quit smoking — reduce nicotine in cigarett
Baltimore Sun / Posted yesterday
has a bold proposal to get people to quit smoking — reduce nicotine in cigarettes to non-addictive levels. Dr. Scott Gottlieb, who touted his plan at the Johns Hopkins Bloomberg School of Public Health Thursday, first announced his... Read more
2 related articles
1d
CBS 6 Richmond
FDA OKs new peanut allergy food labelsthis week, noting that they may reduce the risk of developing an allergy. In a
CBS 6 Richmond / Posted yesterday
this week, noting that they may reduce the risk of developing an allergy. In a statement Thursday, Commissioner Dr. Scott Gottlieb said the agency would allow updated labels on some peanut-containing foods in light of a recent study, as well... Read more
3 related articles
1d
WPIX 11 New York
FDA OKs new peanut allergy food labelsthis week, noting that they may reduce the risk of developing an allergy. In a
WPIX 11 New York / Posted yesterday
this week, noting that they may reduce the risk of developing an allergy. In a statement Thursday, Commissioner Dr. Scott Gottlieb said the agency would allow updated labels on some peanut-containing foods in light of a recent study, as well... Read more
3 related articles
1d
KECI Missoula
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasrelapse or become resistant to treatments, which may include chemotherapy, stem
KECI Missoula / Posted yesterday
relapse or become resistant to treatments, which may include chemotherapy, stem cell transplants, and immunotherapy. Dr. Scott Gottlieb, commissioner of the FDA, noted in a statement announcing the approval Wednesday, how gene therapy has "gone... Read more
113 related articles
1d
WCYB 5 Tri-Cities
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasrelapse or become resistant to treatments, which may include chemotherapy, stem
WCYB 5 Tri-Cities / Posted yesterday
relapse or become resistant to treatments, which may include chemotherapy, stem cell transplants, and immunotherapy. Dr. Scott Gottlieb, commissioner of the FDA, noted in a statement announcing the approval Wednesday, how gene therapy has "gone... Read more
113 related articles
1d
KRDO Colorado Springs
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasrelapse or become resistant to treatments, which may include chemotherapy, stem
KRDO Colorado Springs / Posted yesterday
relapse or become resistant to treatments, which may include chemotherapy, stem cell transplants, and immunotherapy. Dr. Scott Gottlieb, commissioner of the FDA, noted in a statement announcing the approval Wednesday, how gene therapy has "gone... Read more
113 related articles
1d
ABC 7 El Paso
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasrelapse or become resistant to treatments, which may include chemotherapy, stem
ABC 7 El Paso / Posted yesterday
relapse or become resistant to treatments, which may include chemotherapy, stem cell transplants, and immunotherapy. Dr. Scott Gottlieb, commissioner of the FDA, noted in a statement announcing the approval Wednesday, how gene therapy has "gone... Read more
113 related articles
1d
News 8000
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasrelapse or become resistant to treatments, which may include chemotherapy, stem
News 8000 / Posted yesterday
relapse or become resistant to treatments, which may include chemotherapy, stem cell transplants, and immunotherapy. Dr. Scott Gottlieb, commissioner of the FDA, noted in a statement announcing the approval Wednesday, how gene therapy has "gone... Read more
113 related articles
1d
The Scientist
FDA Approves Second CAR T-Cell Therapyfrom being a promising concept to a practical solution to deadly and largely un
The Scientist / Posted yesterday
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” FDA Commissioner Scott Gottlieb says in a statement. “There will likely be thousands of lives saved in the next few years because of it,”... Read more
113 related articles
1d
FOX 2 News St. Louis
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasrelapse or become resistant to treatments, which may include chemotherapy, stem
FOX 2 News St. Louis / Posted yesterday
relapse or become resistant to treatments, which may include chemotherapy, stem cell transplants, and immunotherapy. Dr. Scott Gottlieb, commissioner of the FDA, noted in a statement announcing the approval Wednesday, how gene therapy has “gone... Read more
113 related articles
1d
The Hindu
U.S. approves second gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
The Hindu / Posted yesterday
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
1d
Daily Mail
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
Daily Mail / Posted yesterday
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,' FDA Commissioner Dr. Scott Gottlieb said in a statement. Yescarta will cost $373,000 per patient, according to drug-maker Gilead Sciences. Kite... Read more
113 related articles
1d
CBS News
Gene therapy for blood cancer wins FDA approvalbeing a promising concept to a practical solution to deadly and largely untreat
CBS News / Posted yesterday
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
1d
WSFA 12 Montgomery
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WSFA 12 Montgomery / Posted yesterday
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
1d
TribLIVE
FDA approves gene therapy to treat adult lymphomafrom being a promising concept to a practical solution to deadly and largely un
TribLIVE / Posted yesterday
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” FDA Commissioner Scott Gottlieb said in a statement. “This approval demonstrates the continued momentum of this promising new area of medicine... Read more
113 related articles
2d
NBC 2 Fort Myers
FDA approves cutting-edge cancer treatment 'for patients without hope'being a promising concept to a practical solution to deadly and largely untreat
NBC 2 Fort Myers / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
NBC 29 Charlottesville
FDA approves cutting-edge cancer treatment 'for patients without hope'being a promising concept to a practical solution to deadly and largely untreat
NBC 29 Charlottesville / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
ABC 7 Gulfshore News
FDA approves cutting-edge cancer treatment 'for patients without hope'being a promising concept to a practical solution to deadly and largely untreat
ABC 7 Gulfshore News / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
Reuters
FDA approves Gilead cancer gene therapy; price set at $373,000from being a promising concept to a practical solution to deadly and largely un
Reuters / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” FDA Commissioner Scott Gottlieb said in a statement. In a pivotal clinical trial of more than 100 adults, 51 percent of patients treated with... Read more
113 related articles
2d
Channel NewsAsia
US FDA approves Gilead cancer gene therapy; price set at US$373,000from being a promising concept to a practical solution to deadly and largely un
Channel NewsAsia / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Scott Gottlieb said in a statement. In a pivotal clinical trial of more than 100 adults, 51 percent of patients treated with... Read more
113 related articles
2d
CTV News
U.S. regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
CTV News / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to... Read more
113 related articles
2d
Reuters
U.S. FDA approves Gilead cancer gene therapy; price set at $373,000from being a promising concept to a practical solution to deadly and largely un
Reuters / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” FDA Commissioner Scott Gottlieb said in a statement. In a pivotal clinical trial of more than 100 adults, 51 percent of patients treated with... Read more
113 related articles
2d
The Jewish Press
Kite Pharma, Launched by Israeli Scientists, Gets FDA Approval for Lymphoma Treatment | 29 Tishri 5778 – October 19, 2017being a promising concept to a practical solution to deadly and largely untreat
The Jewish Press / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” said FDA Commissioner Scott Gottlieb, M.D. “This approval demonstrates the continued momentum of this promising new area of medicine and we’re... Read more
113 related articles
2d
WECT 6 Wilmington
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WECT 6 Wilmington / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
Stamford Advocate
A cancer treatment that's part of 'a big new field of medicine' just got approved (GILD)from being a promising concept to a practical solution to deadly and largely un
Stamford Advocate / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Scott Gottlieb said in a news release. How CAR-T therapies work Yescarta isn't your run-of-the-mill pill — or even a... Read more
113 related articles
2d
Connecticut Post
A cancer treatment that's part of 'a big new field of medicine' just got approved (GILD)from being a promising concept to a practical solution to deadly and largely un
Connecticut Post / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Scott Gottlieb said in a news release. How CAR-T therapies work Yescarta isn't your run-of-the-mill pill — or even a... Read more
113 related articles
2d
Channel NewsAsia
China biotech's 'coming out party' masks long road aheadthey are trying to transition to being more of a novel drug development environ
Channel NewsAsia / Posted 2 days ago
they are trying to transition to being more of a novel drug development environment and bring in more innovative research," Scott Gottlieb, head of the U.S. Food and Drug Administration (FDA), told Reuters. "I think it's going to be a long... Read more
2d
Reuters
China biotech's 'coming out party' masks long road aheadthey are trying to transition to being more of a novel drug development environ
Reuters / Posted 2 days ago
they are trying to transition to being more of a novel drug development environment and bring in more innovative research,” Scott Gottlieb, head of the U.S. Food and Drug Administration (FDA), told Reuters. “I think it’s going to be a long... Read more
2d
KWWL Iowa
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
KWWL Iowa / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
WBOC Salisbury
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WBOC Salisbury / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
WFMJ Youngstown
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WFMJ Youngstown / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
WLOX-TV Biloxi
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WLOX-TV Biloxi / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
WIS News 10 Columbia
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WIS News 10 Columbia / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
ABC Montana
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
ABC Montana / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
Jefferson City News Tribune
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
Jefferson City News Tribune / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
Boston Globe
FDA backs gene therapy for cancerin the development of a whole new scientific paradigm for the treatment of seri
Boston Globe / Posted 2 days ago
in the development of a whole new scientific paradigm for the treatment of serious diseases,” the FDA commissioner, Scott Gottlieb, said in a statement. “In just several decades, gene therapy has gone from being a promising concept to a... Read more
113 related articles
2d
Lake Placid News
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
Lake Placid News / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
FOX Business
FDA approves Gilead cancer gene therapy; price set at $373,000from being a promising concept to a practical solution to deadly and largely un
FOX Business / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Scott Gottlieb said in a statement. In a pivotal clinical trial of more than 100 adults, 51 percent of patients treated with... Read more
113 related articles
2d
FOX Business
FDA approves Gilead cancer gene therapy; price set at $373,000from being a promising concept to a practical solution to deadly and largely un
FOX Business / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Scott Gottlieb said in a statement. In a pivotal clinical trial of more than 100 adults, 51 percent of patients treated with... Read more
113 related articles
2d
Business Insider
A cancer treatment that's part of 'a big new field of medicine' just got approvedfrom being a promising concept to a practical solution to deadly and largely un
Business Insider / Posted 2 days ago
from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Scott Gottlieb said in a news release. How CAR-T therapies work Yescarta isn't your run-of-the-mill pill — or even a... Read more
113 related articles
2d
WAVE 3 Louisville
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
WAVE 3 Louisville / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
2d
Your Hometown Lima Stations
US regulators approve 2nd gene therapy for blood cancerbeing a promising concept to a practical solution to deadly and largely untreat
Your Hometown Lima Stations / Posted 2 days ago
being a promising concept to a practical solution to deadly and largely untreatable forms of cancer," FDA Commissioner Dr. Scott Gottlieb said in a statement. The treatment, called Yescarta, will cost $373,000 per patient, according to drugmaker... Read more
113 related articles
More

In this news